CIK: 0001664974 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $163,469 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| OKLO | Oklo Inc. | 6,920,804 | $55,989 | 34.3% | $11.25 | -33.0% | COM CL A | 02156V109 |
| EVLV | Evolv Technologies Holdings, Inc. | 9,681,281 | $39,209 | 24.0% | $5.61 | -37.8% | COM CL A | 30049H102 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $39,152 | 24.0% | $18.82 | -61.9% | CL A | 75629V104 |
| — | Rocket Lab USA, Inc. | 2,929,350 | $28,503 | 17.4% | $4.04 | — | COM | 773122106 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $571 | 0.3% | $3.17 | — | COM NEW | 60255C885 |
| ROIV | Roivant Sciences Ltd. | 3,875 | $45 | 0.0% | $5.56 | +104.7% | SHS | G76279101 |